The European Bank for induced Pluripotent Stem Cells (EBiSC) and CHDI Foundation have collaborated with Censo Biotechnologies to generate a cohort of 45 iPSC lines derived from Huntington’s disease gene-expansion carriers and associated controls. These new lines will be used to further investigate the mechanisms of HD progression and for the development of novel therapeutics and will be widely available to any interested researcher via the EBiSC catalog at cells.ebisc.org.
Read More
Health Rss 